Corpus Intelligence IC Memo — ADVANCED CARE HOSPITAL OF SOUTHERN N 2026-04-26 14:08 UTC
IC Memo — ADVANCED CARE HOSPITAL OF SOUTHERN N
Investment Committee Memorandum | NM | 20 beds | Grade D | EBITDA uplift $713K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ADVANCED CARE HOSPITAL OF SOUTHERN N

CCN 322004 | DONA ANA, NM | 20 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

ADVANCED CARE HOSPITAL OF SOUTHERN N is a 20-bed community hospital in DONA ANA, NM with $9.6M in net patient revenue and a -0.3% operating margin. The hospital serves a payer mix of 30.6% Medicare, 0.0% Medicaid, and 69.4% commercial.

Thesis: Turnaround. Our ML models identify $713K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.3% to 7.2% (+743bps).

Net Revenue HCRIS$9.6M
Current EBITDA COMPUTED$-26K
Operating Margin COMPUTED-0.3%
Occupancy HCRIS71.5%
Revenue / Bed COMPUTED$480K
Net-to-Gross HCRIS44.5%
Distress Probability MLnan%

2. Market Context & Competitive Position

55
NM Hospitals
-2.7%
State Median Margin
23
Comparable Hospitals

NM has 55 Medicare-certified hospitals with a median operating margin of -2.7%. The target's margin of -0.3% places it above the state median. Among 23 size-comparable peers (10-40 beds), the median margin is -17.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (10-40), prioritizing same-state peers. 23 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ADVANCED CARE HOSPITAL OF SOUT (Target)NM20$9.6M-0.3%
NOR-LEA HOSPITALNM25$131.5M0.9%
SANTA FE MEDICAL CENTERNM36$95.0M-26.5%
GILA REGIONAL MEDICAL CENTERNM25$83.6M-3.6%
HOLY CROSS HOSPITALNM25$72.9M-20.0%
LINCOLN COUNTY MEDICAL CENTERNM25$66.7M4.1%
LOVELACE REGIONAL HOSPITAL-ROSNM27$63.1M9.3%
ARTESIA GENERAL HOSPITALNM25$63.0M-17.5%
MIMBRES MEMORIAL HOSPITALNM25$56.6M14.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $713K (743bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$202K+210bp18mo
Denial Rate Reduction12.0%6.5%$193K+201bp12mo
Cost to Collect4.5%2.5%$192K+200bp12mo
A/R Days Reduction5200.0%3800.0%$117K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+10bp6mo

5. EBITDA Bridge

Net Collection Rate
$202K
Denial Rate Reduction
$193K
Cost to Collect
$192K
A/R Days Reduction
$117K
Clean Claim Rate
$10K
Total EBITDA Uplift$713K
Current EBITDA$-26K
+ RCM Uplift+$713K
Pro Forma EBITDA$687K
Current Margin-0.3%
Pro Forma Margin7.2%
WC Released (1x)$368K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-40K$7.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-40K$7.6M0.00x-100.0%
Bull Case9.0x11.0x$-36K$10.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-36K$10.9M0.00x-100.0%
Bear Case11.0x10.0x$-44K$3.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-44K$3.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 23 hospitals with 10-40 beds
  • Same-state prioritization (n=24)
  • Comp margins: P25=-25.1% / P50=-17.5% / P75=4.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.